Showing 1 - 20 results of 313 for search '"Brain Neoplasms pathology"', query time: 1.48s Refine Results
1
2
3
4
5
6

Contributors: Broad Institute of MIT and Harvard, Massachusetts Institute of Technology. Department of Biology, Koch Institute for Integrative Cancer Research at MIT, Dionne, Danielle, Golub, Todd, Getz, Gad Asher, Bernstein, Bradley, Regev, Aviv

Source: Science, vol. 355, no. 6332, pp. 1391
PMC

File Description: application/pdf

7

Contributors: Laboratoire des Substances Naturelles (LR02INRAP10), Institut National de Recherche et d'Analyse Physico-chimique (INRAP-Tunisie), Faculté de Médecine de Tunis, Université Tunis El Manar (UTM), Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Faculté des Sciences de Tunis, Université de Tunis [Tunis], Centre de Recherches en Oncologie biologique et Oncopharmacologie (CRO2), Aix Marseille Université (AMU)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), This research was supported by Ministry of High Education and Scientific Research of Tunisia (MERST) and the Institut National de la Santé et de la Recherche Médicale (INSERM) and by grants from INCa (Institut National du Cancer) and ARCUS (Action en Région de Coopération Universitaire et Scientifique).

Source: Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2016, 84, pp.1223-1232. ⟨10.1016/j.biopha.2016.10.035⟩

8

Contributors: Laboratoire des Substances Naturelles (LR02INRAP10), Institut National de Recherche et d'Analyse Physico-chimique [Ariana, Tunisie] (INRAP), Laboratoire des Venins et Biomolécules Thérapeutiques - Laboratory of Venoms and Therapeutic Biomolecules (LR11IPT08), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Faculté de Médecine de Tunis, Université de Tunis El Manar (UTM), Faculté des Sciences Mathématiques, Physiques et Naturelles de Tunis (FST), Centre de Recherches en Oncologie biologique et Oncopharmacologie (CRO2), Aix Marseille Université (AMU)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), This research was supported by Ministry of High Education and Scientific Research of Tunisia (MERST) and the Institut National de la Santé et de la Recherche Médicale (INSERM) and by grants from INCa (Institut National du Cancer) and ARCUS (Action en Région de Coopération Universitaire et Scientifique).

Source: Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2016, 84, pp.1223-1232. ⟨10.1016/j.biopha.2016.10.035⟩

9
12
13
15
16

Source: British Journal of Cancer
British journal of cancer, vol. 90, no. 5, pp. 1059-1068

File Description: application/pdf

PDF Full Text
17
18

Contributors: Physiopathologie du cancer du foie, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de Médecine Purpan, This work was supported by the Avenir program of Institut National de la Santé et de la Recherche Médicale, Institut national du cancer, Ligue Contre le Cancer to E.C., the French Association pour la Recherche contre le Cancer to O.P., La Ligue contre le Cancer to N.D., and the Cancéropôle Grand Sud-Ouest to C.G., We thank the Chevet lab for critical reading of the manuscript. We are indebted to Sebastien Marais (Bordeaux Imaging Center, Bordeaux, France) for help with the ImageJ program.

Source: Journal of Cell Science
Journal of Cell Science, Company of Biologists, 2012, 125 (18), pp.4278-4287. ⟨10.1242/jcs.099291⟩

19

Source: Analytical Cellular Pathology, Vol 21, Iss 3-4, Pp 177-182 (2000)
Analytical cellular pathology :the journal of the European Society for Analytical Cellular Pathology, 21 (3-4
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology

File Description: 2 full-text file(s): application/pdf; application/pdf; text/xhtml

PDF Full Text
20

Contributors: Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group, European Organisation for, Research, Treatment of Cancer Brain, Tumour, Pathology, CCA - Disease profiling

Source: Acta Neuropathologica, vol. 123, no. 6, pp. 841-852
Acta Neuropathologica, 123(6), 841-852. Springer Verlag
Acta Neuropathologica, 123, 841-852
Hegi, M E; Janzer, R C; Lambiv, W L; Gorlia, T; Kouwenhoven, M C M; Hartmann, C; von Deimling, A; Martinet, D; Besuchet Schmutz, N; Diserens, A C; Hamou, M F; Bady, P; Weller, M; van den Bent, M J; Mason, W P; Mirimanoff, R O; Stupp, R; Mokhtari, K; Wesseling, P (2012). Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial. Acta Neuropathologica, 123(6):841-852.
Acta neuropathologica

File Description: application/pdf